Maria Annunziata to Hidradenitis Suppurativa
This is a "connection" page, showing publications Maria Annunziata has written about Hidradenitis Suppurativa.
Connection Strength
1.152
-
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy. J Dermatolog Treat. 2022 Feb; 33(1):592.
Score: 0.142
-
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study J Drugs Dermatol. 2019 May 01; 18(5):437-438.
Score: 0.132
-
Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance. Br J Dermatol. 2019 04; 180(4):949.
Score: 0.129
-
Insulin resistance, mTOR and hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019 03; 33(3):e106-e107.
Score: 0.127
-
Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience. Clin Exp Dermatol. 2019 04; 44(3):e28-e29.
Score: 0.127
-
An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis suppurativa: our experience. G Ital Dermatol Venereol. 2020 Dec; 155(6):749-753.
Score: 0.126
-
Unconventional therapies for hidradenitis suppurativa. Expert Rev Clin Pharmacol. 2018 Sep; 11(9):879-887.
Score: 0.126
-
Hyperbaric oxygen therapy (HBOT )can improve the effectiveness of adalimumab in hidradenitis suppurativa. G Ital Dermatol Venereol. 2020 Apr; 155(2):234-235.
Score: 0.123
-
A case of axillary hidradenitis suppurativa treated with topical tacrolimus. G Ital Dermatol Venereol. 2019 Oct; 154(5):594-595.
Score: 0.121